Compare · ELV vs HHLA
ELV vs HHLA
Side-by-side comparison of Elevance Health Inc. (ELV) and HH&L Acquisition Co. (HHLA): market cap, price performance, sector, and recent activity on the wire.
Summary
- Both ELV and HHLA operate in Medical Specialities (Health Care), so they compete in similar markets.
- ELV is the larger of the two at $92.91B, about 185.5x HHLA ($500.9M).
- ELV has hit the wire 3 times in the past 4 weeks while HHLA has been quiet.
- ELV has more recent analyst coverage (23 ratings vs 0 for HHLA).
- Company
- Elevance Health Inc.
- HH&L Acquisition Co.
- Price
- $428.56+0.04%
- $10.76+0.09%
- Market cap
- $92.91B
- $500.9M
- 1M return
- -
- -
- 1Y return
- -
- -
- Industry
- Medical Specialities
- Medical Specialities
- Exchange
- NYSE
- NYSE
- IPO
- 2021
- News (4w)
- 3
- 0
- Recent ratings
- 23
- 0
Elevance Health Inc.
Elevance Health Inc. operates as a health benefits company. It supports consumers, families, and communities across the entire care journey connecting to the care, support, and resources to lead healthier lives. It serves approximately 118 million people through a portfolio of medical, digital, pharmacy, behavioral, clinical, and care solutions. The company was formerly known as Anthem, Inc. and changed its name to Elevance Health Inc. in June 2022. Elevance Health Inc. was founded in 1944 and is headquartered in Indianapolis, Indiana.
HH&L Acquisition Co.
HH&L Acquisition Co. is a blank check company. HH&L Acquisition Co. was incorporated in 2020 and is based in Central, Hong Kong.
Latest ELV
- SEC Form 4 filed by Elevance Health Inc.
- Elevance Health to Hold Conference Call and Webcast to Discuss Third Quarter 2026 Results on October 21, 2026
- Elevance Health’s Affiliated 2027 Medicare Advantage Plans Advance Stability, Choice and More Coordinated Support
- Elevance Health Inc. filed SEC Form 8-K: Regulation FD Disclosure
- EVP & Chief Legal Officer Wessling Erin M covered exercise/tax liability with 349 shares, decreasing direct ownership by 5% to 7,230 units (SEC Form 4)
- EVP & Chief HR Officer Craig Ryan R covered exercise/tax liability with 144 shares, decreasing direct ownership by 2% to 6,530 units (SEC Form 4)
- Elevance Health Strengthens Connected Cancer Care Model to Support Consumers Through Their Health Journey
- Director Peru Ramiro G bought $366,050 worth of shares (1,000 units at $366.05), increasing direct ownership by 10% to 10,908 units (SEC Form 4)
- President and CEO Boudreaux Gail bought $1,002,230 worth of shares (2,725 units at $367.79), increasing direct ownership by 2% to 171,976 units (SEC Form 4)
- SEC Form 10-Q filed by Elevance Health Inc.
Latest HHLA
- SEC Form 25-NSE filed by HH&L Acquisition Co.
- SEC Form SC 13G filed by HH&L Acquisition Co.
- SEC Form SC 13G filed by HH&L Acquisition Co.
- SEC Form SC 13G/A filed by HH&L Acquisition Co. (Amendment)
- SEC Form SC 13G filed by HH&L Acquisition Co.
- SEC Form SC 13G filed by HH&L Acquisition Co.
- SEC Form SC 13G/A filed by HH&L Acquisition Co. (Amendment)
- SEC Form SC 13G/A filed by HH&L Acquisition Co. (Amendment)
- HH&L Acquisition Co. Shares Halted Under Code News Pending
- HH&L Acquisition Co Decides That It Will Redeem All Of Its Outstanding Ordinary Shares That Were Included In Units Issued In Its IPO; Per-Share Redemption Price For Public Shares Will Be About $10.79, Before Payment Of Taxes And Dissolution Expenses